Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec;10(24):1415.
doi: 10.21037/atm-2022-60.

Pharmacogenetic screening in a knowledge-based economy: shouldn't more be better?

Affiliations
Editorial

Pharmacogenetic screening in a knowledge-based economy: shouldn't more be better?

David A Alter. Ann Transl Med. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-2022-60/coif). The author is the founder of My Heart Fitness Inc., which is a learning management system for patients in need of therapeutic lifestyle management.

Comment on

References

    1. OECD/Eurostat (2005). Oslo Manual: Guidelines for Collecting and Interpreting Innovation Data, 3rd Edition, The Measurement of Scientific and Technological Activities, OECD Publishing, Paris. Available online: https://doi.org/10.1787/9789264013100-en - DOI
    1. Vassy JL, Gaziano JM, Green RC, et al. Effect of pharmacogenetic testing for statin myopathy risk vs usual care on blood cholesterol: a randomized clinical trial. JAMA Netw Open 2020;3:e2027092. 10.1001/jamanetworkopen.2020.27092 - DOI - PMC - PubMed
    1. Connelly M, Hernandez MM, Alvarez E, et al. NORC University of Chicago; Associated Press; genetic testing: ancestry interest, but privacy concerns. 2018. Available online: https://reports.norc.org/issue_brief/genetic-testing-ancestry-interest-b...
    1. US Food and Drug Administration. The FDA warns against the use of many genetic tests with unapproved claims to predict patient response to specific medications: FDA safety communication. Published October 31, 2018. Updated April 4, 2019. Accessed September 29, 2020. Available online: https://www.raps.org/news-and-articles/news-articles/2018/11/fda-warns-a...
    1. US Food and Drug Administration.Warning letter: Inova Genomics Laboratory (MARCS-CMS 577422). Updated April 4, 2019. Accessed September 29, 2020. Available online: https://www.fda.gov/news-events/press-announcements/fda-issues-warning-l...